Devron H. Char

9.7k total citations
231 papers, 6.3k citations indexed

About

Devron H. Char is a scholar working on Ophthalmology, Oncology and Molecular Biology. According to data from OpenAlex, Devron H. Char has authored 231 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 171 papers in Ophthalmology, 65 papers in Oncology and 42 papers in Molecular Biology. Recurrent topics in Devron H. Char's work include Ocular Oncology and Treatments (154 papers), Cutaneous Melanoma Detection and Management (33 papers) and Retinal Development and Disorders (22 papers). Devron H. Char is often cited by papers focused on Ocular Oncology and Treatments (154 papers), Cutaneous Melanoma Detection and Management (33 papers) and Retinal Development and Disorders (22 papers). Devron H. Char collaborates with scholars based in United States, Germany and United Kingdom. Devron H. Char's co-authors include Theodore R. Miller, Stewart Kroll, Joseph R. Castro, Theodore L. Phillips, Jeanne M. Quivey, Joanna Crawford, J. William Harbour, Robert D. Stone, Murat Tunç and Alexander R. Irvine and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Devron H. Char

229 papers receiving 5.9k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Devron H. Char 4.5k 1.8k 1.3k 1.1k 738 231 6.3k
Paul T. Finger 5.9k 1.3× 2.2k 1.2× 2.0k 1.5× 1.0k 1.0× 1.0k 1.4× 264 7.4k
James J. Augsburger 6.0k 1.3× 1.6k 0.9× 1.8k 1.4× 1.4k 1.3× 755 1.0× 269 7.2k
Laurence Desjardins 3.5k 0.8× 1.7k 0.9× 898 0.7× 1.3k 1.2× 529 0.7× 188 5.0k
Arun D. Singh 6.9k 1.5× 2.9k 1.6× 1.9k 1.5× 2.5k 2.3× 939 1.3× 443 9.3k
Tero Kivelä 5.4k 1.2× 1.8k 1.0× 2.2k 1.7× 2.5k 2.3× 664 0.9× 254 8.0k
Bertil Damato 7.2k 1.6× 3.2k 1.8× 1.9k 1.5× 2.7k 2.5× 816 1.1× 308 8.8k
John D. Earle 2.1k 0.5× 1.6k 0.9× 1.1k 0.9× 826 0.8× 1.2k 1.6× 127 6.9k
Brian P. Marr 3.5k 0.8× 1.3k 0.7× 1.0k 0.8× 943 0.9× 865 1.2× 155 4.6k
Nathalie Cassoux 3.2k 0.7× 1.3k 0.7× 414 0.3× 769 0.7× 668 0.9× 218 5.7k
Dion Paridaens 2.4k 0.5× 1.1k 0.6× 506 0.4× 909 0.8× 398 0.5× 174 3.8k

Countries citing papers authored by Devron H. Char

Since Specialization
Citations

This map shows the geographic impact of Devron H. Char's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Devron H. Char with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Devron H. Char more than expected).

Fields of papers citing papers by Devron H. Char

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Devron H. Char. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Devron H. Char. The network helps show where Devron H. Char may publish in the future.

Co-authorship network of co-authors of Devron H. Char

This figure shows the co-authorship network connecting the top 25 collaborators of Devron H. Char. A scholar is included among the top collaborators of Devron H. Char based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Devron H. Char. Devron H. Char is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Minor, David R., Kevin B. Kim, Ricky T. Tong, et al.. (2022). A Pilot Study of Hepatic Irradiation with Yttrium-90 Microspheres Followed by Immunotherapy with Ipilimumab and Nivolumab for Metastatic Uveal Melanoma. Cancer Biotherapy and Radiopharmaceuticals. 37(1). 11–16. 10 indexed citations
2.
Mishra, Kavita, Armin R. Afshar, Juliette Thariat, et al.. (2020). Practice Considerations for Proton Beam Radiation Therapy of Uveal Melanoma During the Coronavirus Disease Pandemic: Particle Therapy Co-Operative Group Ocular Experience. Advances in Radiation Oncology. 5(4). 682–686. 8 indexed citations
3.
Mishra, Kavita, Jessica Scholey, Inder Daftari, et al.. (2020). Oral isotretinoin and topical retinoid use in a series of young patients with ocular melanoma. American Journal of Ophthalmology Case Reports. 19. 100787–100787. 3 indexed citations
4.
Mishra, Kavita, Jeanne M. Quivey, Inder Daftari, et al.. (2015). Long-term Results of the UCSF-LBNL Randomized Trial: Charged Particle With Helium Ion Versus Iodine-125 Plaque Therapy for Choroidal and Ciliary Body Melanoma. International Journal of Radiation Oncology*Biology*Physics. 92(2). 376–383. 52 indexed citations
5.
Char, Devron H., et al.. (2010). Fibrous Dysplasia. Orbit. 29(4). 216–218. 3 indexed citations
6.
Worley, Lori A., et al.. (2007). Transcriptomic versus Chromosomal Prognostic Markers and Clinical Outcome in Uveal Melanoma. Clinical Cancer Research. 13(5). 1466–1471. 124 indexed citations
7.
Onken, Michael D., et al.. (2007). Loss of Heterozygosity of Chromosome 3 Detected with Single Nucleotide Polymorphisms Is Superior to Monosomy 3 for Predicting Metastasis in Uveal Melanoma. Clinical Cancer Research. 13(10). 2923–2927. 95 indexed citations
8.
Harbour, J. William, et al.. (2007). Chromosome 8p Status Predicts Disease-Free Survival in Aggressive Class 2 Uveal Melanomas. Investigative Ophthalmology & Visual Science. 48(13). 1942–1942. 1 indexed citations
9.
Rajendran, R., Vivian Weinberg, Inder Daftari, et al.. (2004). Decreased incidence of neovascular glaucoma by sparing anterior structures of the eye for proton beam therapy of ocular melanoma. International Journal of Radiation Oncology*Biology*Physics. 60(1). S311–S312. 6 indexed citations
10.
Char, Devron H., et al.. (2000). SMALL CHOROIDAL MELANOMA WITH INTRAOCULAR SPREAD. Retina. 20(4). 409–409. 4 indexed citations
11.
Tunç, Murat, et al.. (1999). Intraepithelial and invasive squamous cell carcinoma of the conjunctiva: analysis of 60 cases. British Journal of Ophthalmology. 83(1). 98–103. 172 indexed citations
12.
Arroyo, Jorge G., Siavash Ghazvini, & Devron H. Char. (1997). An immunocytochemical study of isolated human retinal M�ller tells in culture. Graefe s Archive for Clinical and Experimental Ophthalmology. 235(7). 411–414. 6 indexed citations
13.
Faktorovich, Ella G., Joanna Crawford, Devron H. Char, & Christina S. Kong. (1996). Benign Mixed Tumor (Pleomorphic Adenoma) of the Lacrimal Gland in a 6-year-old Boy. American Journal of Ophthalmology. 122(3). 446–447. 21 indexed citations
14.
Kurhanewicz, John, et al.. (1991). 31P magnetic resonance spectroscopy (MRS) of experimental orbital myositis.. PubMed. 32(8). 2417–22. 4 indexed citations
15.
Chen, Thomas C., et al.. (1990). Flow Cytometry Measurement of Nuclear RNA Content in Uveal Melanoma. Ophthalmic Research. 22(3). 187–193. 5 indexed citations
16.
Char, Devron H.. (1989). Iris Melanoma With Increased Intraocular Pressure. Archives of Ophthalmology. 107(4). 548–548. 13 indexed citations
17.
Char, Devron H., Britt‐Marie Ljung, Theodore R. Miller, & Theodore L. Phillips. (1988). Primary Intraocular Lymphoma (ocular reticulum cell sarcoma) Diagnosis and Management. Ophthalmology. 95(5). 625–630. 160 indexed citations
18.
Char, Devron H.. (1980). The management of lid and conjunctival malignancies. Survey of Ophthalmology. 24(6). 679–689. 23 indexed citations
19.
Char, Devron H.. (1978). Immunology of uveitis and ocular tumors. Grune & Stratton eBooks. 7 indexed citations
20.
Char, Devron H., et al.. (1973). Cutaneous delayed hypersensitivity responses to tumor‐associated and other antigens in acute leukemia. International Journal of Cancer. 12(2). 409–419. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paul T. Finger Breakdown of academic impact, for papers by James J. Augsburger Breakdown of academic impact, for papers by Laurence Desjardins Breakdown of academic impact, for papers by Arun D. Singh Breakdown of academic impact, for papers by Tero Kivelä Breakdown of academic impact, for papers by Bertil Damato Breakdown of academic impact, for papers by John D. Earle Breakdown of academic impact, for papers by Brian P. Marr Breakdown of academic impact, for papers by Nathalie Cassoux Breakdown of academic impact, for papers by Dion Paridaens
Rankless by CCL
2026